COMPARING ROC CURVE OF RISK WEIGHT CALCULATION WITH RISK RATIOS OF CANDIDATE RISK FACTORS FOR INCIDENT MAJOR OSTEOPOROTIC FRACTURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
作者
Yoshi, I. [1 ]
Sawada, N. [2 ]
Chijiwa, T. [3 ]
机构
[1] Yoshii Clin, Musculoskeletal Med, Shimano City, Japan
[2] Dohgo Onsen Hosp, Rheumatol, Matsuyama, Japan
[3] Kochi Mem Hosp, Rheumatol, Kochi, Japan
关键词
Outcome measures; Validation; Bone;
D O I
10.1136/annrheumdis-2024-eular.891
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB057
引用
收藏
页数:2
相关论文
共 31 条
  • [21] Sarcopenia and Nutrition in Elderly Rheumatoid Arthritis Patients: A Cross-Sectional Study to Determine Prevalence and Risk Factors
    Cano-Garcia, Laura
    Manrique-Arija, Sara
    Dominguez-Quesada, Carmen
    Vacas-Perez, Juan Crisostomo
    Armenteros-Ortiz, Pedro J. J.
    Ruiz-Vilchez, Desire
    Martin-Martin, Jose Maria
    Redondo-Rodriguez, Rocio
    Garcia-Studer, Aimara
    Ortiz-Marquez, Fernando
    Mena-Vazquez, Natalia
    Fernandez-Nebro, Antonio
    NUTRIENTS, 2023, 15 (11)
  • [22] Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment
    de Thurah, Annette
    Andersen, Ina Trolle
    Tinggaard, Andreas Bugge
    Riis, Anders Hammerich
    Therkildsen, Josephine
    Botker, Hans Erik
    Bottcher, Morthen
    Hauge, Ellen-Margrethe
    RMD OPEN, 2020, 6 (01):
  • [23] Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease
    Hornberg, Kristina
    Sundstrom, Bjorn
    Innala, Lena
    Rantapaa-Dahlqvist, Solbritt
    Wallberg-Jonsson, Solveig
    PLOS ONE, 2017, 12 (12):
  • [24] Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis?
    Martins, Ana
    Pimenta, Sofia
    Oliveira, Daniela
    Nicolau, Rafaela
    Bernardo, Alexandra
    Rocha, Teresa Martins
    Costa, Lucia
    Bernardes, Miguel
    REUMATOLOGIA CLINICA, 2024, 20 (07): : 380 - 385
  • [25] Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink
    Abtahi, Shahab
    Driessen, Johanna H. M.
    Burden, Andrea M.
    Souverein, Patrick C.
    van den Bergh, Joop P.
    van Staa, Tjeerd P.
    Boonen, Annelies
    de Vries, Frank
    RHEUMATOLOGY, 2022, 61 (04) : 1448 - 1458
  • [26] Impact of biologic disease-modifying antirheumatic drugs on fracture risk in patients with rheumatoid arthritis: a systematic review and meta-analysis
    Shao, F.
    Li, H. C.
    Wang, M. J.
    Cui, C. M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (09) : 3416 - 3424
  • [27] Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: Results from a large prospective observational cohort study
    Ishida, Osamu
    Furuya, Takefumi
    Inoue, Eisuke
    Ochi, Kensuke
    Ikari, Katsunori
    Taniguchi, Atsuo
    Yamanaka, Hisashi
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2015, 25 (03) : 373 - 378
  • [28] Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'
    Lin, Tsung-Kun
    Pan, Lung-Fa
    Jong, Gwo-Ping
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E141 - E141
  • [29] Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over
    Roussy, J. -P.
    Bessette, L.
    Bernatsky, S.
    Rahme, E.
    Lachaine, J.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (09) : 2483 - 2492
  • [30] FRAX 10-year fracture risk in rheumatoid arthritis assessed with and without bone mineral density are we treating our patients under bDMARDs?
    Seabra Rato, M.
    Oliveira Pinheiro, F.
    Garcia, S.
    Fernandes, B.
    Bernardo, A.
    Gaio, R.
    Costa, L.
    Benardes, M.
    ARP RHEUMATOLOGY, 2023, 2 (01): : 47 - 52